A R MacLeod - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

A R MacLeod

Showing results (31-40 of 32) with videos related to

Pageof 4

Sort By:

You have reached the last page of results.This site can display upto 32 results.

Oncogene|September 22, 2015

Targeting PYK2 mediates microenvironment-specific cell death in multiple myelomaM B Meads, B Fang, L Mathews, et al.

International Journal of Cancer|May 20, 2016

Modulation of tumor eIF4E by antisense inhibition: A phase I/II translational clinical trial of ISIS 183750-an antisense oligonucleotide against eIF4E-in combination with irinotecan in solid tumors and irinotecan-refractory colorectal cancerA G Duffy, O V Makarova-Rusher, S V Ulahannan, et al.

Pageof 4

Search research articles

Showing results (31-40 of 32) with videos related to

Sort By:

Pageof 4

You have reached the last page of results.This site can display upto 32 results.

Oncogene|September 22, 2015

Targeting PYK2 mediates microenvironment-specific cell death in multiple myelomaM B Meads, B Fang, L Mathews, et al.

International Journal of Cancer|May 20, 2016

Modulation of tumor eIF4E by antisense inhibition: A phase I/II translational clinical trial of ISIS 183750-an antisense oligonucleotide against eIF4E-in combination with irinotecan in solid tumors and irinotecan-refractory colorectal cancerA G Duffy, O V Makarova-Rusher, S V Ulahannan, et al.

Pageof 4